Regencell Bioscience Holdings has seen a sharp re-rating over the past three years, with its shares trading at a P/B multiple far above peers, pointing to heavy reliance on the value of its research ...
Source LinkRegencell Bioscience Holdings has seen a sharp re-rating over the past three years, with its shares trading at a P/B multiple far above peers, pointing to heavy reliance on the value of its research ...
Source Link
Comments